WELL Health Announces Closing of Second Tranche of Upsized $11M Private Placement of Convertible Debentures Including Mr. Li Ka-shing Mar 16, 2020
WELL Health Provides Corporate Update: Core Clinic and SaaS EMR Revenues Prove to be Resilient and Growing While Telehealth Ramps Up Significantly Mar 13, 2020
WELL Health Announces Upsize of Private Placement Of Convertible Debentures to $11.0 Million To Include Mr. Li Ka-shing Mar 13, 2020
Coronavirus Declared a Pandemic as Ovation Receives Interest for DermSafe from More Countries with the Coronavirus (COVID-19) Mar 12, 2020
Japan’s Regulatory Agency, PMDA, Clears RepliCel Life Sciences to Proceed to Final Consultation for Tendon and Skin Cell Therapy Products Mar 11, 2020
Ovation Steps Up as Supplier to CFL to Help Keep Prospects and Staff Safe In Midst of Worldwide Concern Over COVID-19 (Coronavirus) Mar 11, 2020
Japan’s Patent Office Issues RepliCel Two New Patents for its Regenerative Medicine Technologies Mar 10, 2020
WELL Health Announces Flu Surveillance Partnership with McMaster University and the Public Health Agency of Canada Mar 10, 2020
Production of Dermal Injectors Delayed by China Work Stoppage Effecting Critical Component Mar 9, 2020
Search Minerals Receives Funding From Atlantic Canada Opportunities Agency for Cost and Design Studies Mar 3, 2020
